FILE- This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Jan. 29, 2019. (AP Photo/Richard Drew, File)

Weak outlook from Pfizer overshadows 4Q performance

January 29, 2019 - 7:09 am

NEW YORK (AP) — Pfizer's strong profit for the fourth quarter is being overshadowed by a tepid outlook for the year.

The drugmaker on Tuesday had a loss of $394 million, or 7 cents per share. Adjusted for non-recurring costs and costs related to mergers and acquisitions, however, per-share earnings were 64 cents per share, a penny better than expected, according to a survey by Zacks Investment Research.

Revenue was $13.98 billion.

Pfizer Inc. expects full-year earnings in the range of $2.82 to $2.92 per share. Industry analysts have been expecting annual per-share earnings of $3.04.

Shares are down more than a percent before the opening bell.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PFE at

AP Editorial Categories: 
Comments ()